Skip to main content
Theodore Johnson, MD, Pediatric Hematology & Oncology, Augusta, GA, Augusta University Medical Center

TheodoreSamuelJohnsonMD

Pediatric Hematology & Oncology Augusta, GA

Assistant Professor, Pediatrics, Medical College of Georgia at Georgia Health Sciences University

Are you Dr. Johnson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 40 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Theodore Johnson, MD is a pediatric hematologist/oncologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia, Ohio, and South Carolina. He is affiliated with Augusta University Medical Center and is an Assistant Professor at Medical College of Georgia at Georgia Health Sciences University.

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • Medical College of Georgia
    Medical College of GeorgiaResidency, Pediatrics, 2004 - 2007
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2004

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2010 - 2024
  • SC State Medical License
    SC State Medical License 2006 - 2017
  • OH State Medical License
    OH State Medical License 2007 - 2012
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: Research
    Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: ResearchApril 25th, 2023
  • Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain Tumors
    Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain TumorsApril 25th, 2023

Hospital Affiliations